The Ozempic vision loss lawsuit alleges that Novo Nordisk and Eli Lilly failed to warn patients about the risk of NAION non-arteritic anterior ischemic optic neuropathy a serious eye condition that causes sudden, often permanent vision loss due to loss of blood flow to the optic nerve
Changes in Flow or Bleeding Pattern A few people report: heavier bleeding than normal very light bleeding shorter or longer periods These changes usually reflect how your body responds to weight loss and hormonal shifts, rather than a direct effect of the medicine
6 A large meta-analysis of randomised controlled trials published in 2024 found no significant association between GLP-1 medications and psychiatric disorders overall, but the authors noted that ongoing monitoring is advisable
Many patients with controlled Graves disease seek weight management solutions, raising questions about tirzepatide safety in this population
Riddhi Doshi: Employee of IQVIA who received funding from Novo Nordisk Inc
When buying horse gelatin, look for third-party certifications (like NSF or Informed-Sport) and clear labeling of a GMP-compliant facility